Adalimumab, Anti-tumour necrosis factor, Biologic therapy, Etanercept, Oligoarticular juvenile idiopathic arthritis, Response
dx.doi.org/10.1093/rheumatology/kes373, hdl.handle.net/1765/65403
Rheumatology (Oxford, England)
Department of Pediatrics

Anink, J, Otten, M.H, Prince, F.H.M, Hoppenreijs, E.P.A.H, Wulffraat, N.M, Swart, J.F, … van Suijlekom-Smit, L.W.A. (2013). Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: Results from the dutch arthritis and biologicals in children register. Rheumatology (Oxford, England), 52(4), 712–717. doi:10.1093/rheumatology/kes373